COVID-19 preclinical drug development database
Cellular and molecular drivers of SARS-CoV-2 tissue damage in COVID-19 deceased patients
Imperial College London
Added 06/07/2020 | Updated 04/10/2021
Project Details
Type of project
- Supporting technologies, models and assays
- Single cell 'omics approaches
Therapeutic target
- Not known
Type of supporting technology
Phase of project
- Single cell 'omics approaches on diseased tissues
Modality (if can be disclosed)*
Molecular/cellular target (if known or can be disclosed)*
- A whole genome approach
Partner institutions/organisations
- National Heart and Lung Institute
- Wellcome Sanger Institute
Key contact
Name: Dr Michela Noseda
Email Address: [email protected]
Phone Number: 07515276135
Key Collaborators:
Dr Michela Noseda and Dr Michael Osborn - Imperial College
Dr Omer Bayraktar and Dr Sarah Teichmann - Wellcome Sanger Institute
Anticipated timeframe of future outputs
This research project is looking for the following:
Autopsy and post-mortem tissues (snap frozen and FFPE)Similar Projects
Project Name
Lead institution
